Integrative pathway enrichment analysis of multivariate omics data.

Paczkowska, Marta; Barenboim, Jonathan; Sintupisut, Nardnisa; Fox, Natalie S; Zhu, Helen; Abd-Rabbo, Diala; Mee, Miles W; Boutros, Paul C; Reimand, Jüri (2020). Integrative pathway enrichment analysis of multivariate omics data. Nature communications, 11(1), p. 735. 10.1038/s41467-019-13983-9

[img]
Preview
Text
41467_2019_Article_13983.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (6MB) | Preview

Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high-dimensional molecular profiles pose challenges to data interpretation and hypothesis generation. ActivePathways is an integrative method that discovers significantly enriched pathways across multiple datasets using statistical data fusion, rationalizes contributing evidence and highlights associated genes. As part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumor types, we integrated genes with coding and non-coding mutations and revealed frequently mutated pathways and additional cancer genes with infrequent mutations. We also analyzed prognostic molecular pathways by integrating genomic and transcriptomic features of 1780 breast cancers and highlighted associations with immune response and anti-apoptotic signaling. Integration of ChIP-seq and RNA-seq data for master regulators of the Hippo pathway across normal human tissues identified processes of tissue regeneration and stem cell regulation. ActivePathways is a versatile method that improves systems-level understanding of cellular organization in health and disease through integration of multiple molecular datasets and pathway annotations.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2041-1723

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

31 Aug 2020 17:27

Last Modified:

31 Mar 2021 08:35

Publisher DOI:

10.1038/s41467-019-13983-9

PubMed ID:

32024846

Additional Information:

Collaborator PCAWG Drivers and Functional Interpretation Working Group: Rory Johnson (Clinic of Medical Oncology)
DBMR Collaborator: Mark A. Rubin (Director DBMR, Precision Medicine)

BORIS DOI:

10.7892/boris.146114

URI:

https://boris.unibe.ch/id/eprint/146114

Actions (login required)

Edit item Edit item
Provide Feedback